Experiment 449815

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationBURRIS,H: IRVIN,R: KUHN,J: KOLTER,S: SMITH,L: SHAFFER,D: FIELDS,S: WEISS,G: ECKARDT,J: RODRIGUEZ,G: RINOLDI,D: WALL,J: COOK,G: SMITH,S: VREELAND,F: BAYSSAS,M: LE BAIL,N: VON HOFF,D:. (1993). PHASE I CLINICAL TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR 6-HOUR INTRAVENOUS INFUSION.. 11(5)
Amount utilized
Compound isolated
DiseasePLASMA CONCENTRATION DECLINED IN A TRIEXPONENTIAL MANNER, WITH A TERMINAL HALF-LIFE OF 11.8 HOURS.
Dose amountVAR
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE